Document Detail

Epidemiology of von Willebrand disease in developing countries.
MedLine Citation:
PMID:  16276466     Owner:  NLM     Status:  MEDLINE    
There is limited information on von Willebrand disease (vWD) in developing countries. A questionnaire survey in 1998 showed that overall, less than one third of the expected number of patients with vWD in the population had been detected. Among those registered, the proportion with the severe form of the disease was relatively higher, forming up to 50% of the total, particularly in those countries with high prevalence of consanguineous marriages. Diagnosis was based on von Willebrand factor antigen (vWF:Ag) assays, vWF ristocetin cofactor (vWF:Rco) activity, and ristocetin-induced platelet aggregation (RIPA) at the reporting centers, but vWF multimer analysis was not widely available. Responsiveness to desmopressin acetate (DDAVP), which could be very significant clinically, was not often assessed. An attempt was made to assess accuracy of reporting of the prevalence of vWD by conducting a second survey aimed at normalizing the reported numbers with that of severe hemophilia A in a defined population on the presumption that the latter is less likely to be missed. These data showed that in most countries, the ratio of patients with vWD to severe hemophilia varied between 0.1 to 0.6 with a mean of approximately 0.4, as opposed to an expected ratio of approximately 1 (based on population-based data from Italy), confirming the underdiagnosis of vWD even within the same health-care system. A system for collecting more extensive and detailed data on vWD from developing countries (where 80% of the world's population lives) is required. Efforts are needed to develop national registries and make at least basic services for diagnosis and treatment widely available.
Alok Srivastava; Francesco Rodeghiero
Related Documents :
24334756 - Living an everyday life through a child's cancer trajectory: families' lived experience...
1759766 - Breast cancer data collection for surgical audit.
22884366 - Luminal iron levels govern intestinal tumorigenesis after apc loss in vivo.
14423026 - An estimate of the prevalence of cancer in india.
20363586 - Systematic review and meta-analysis of the association between p53 codon 72 polymorphis...
17699756 - Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in thrombosis and hemostasis     Volume:  31     ISSN:  0094-6176     ISO Abbreviation:  Semin. Thromb. Hemost.     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-11-08     Completed Date:  2005-12-29     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0431155     Medline TA:  Semin Thromb Hemost     Country:  United States    
Other Details:
Languages:  eng     Pagination:  569-76     Citation Subset:  IM    
Department of Haematology, Christian Medical College, Vellore, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Delivery of Health Care
Developing Countries* / economics
Hemophilia A / epidemiology,  therapy
von Willebrand Diseases / diagnosis,  economics,  epidemiology*,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expanding hemophilia care in developing countries.
Next Document:  Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of ...